HealthTell, Inc., a Chandler, AZ-based biotech spinout from Arizona State University, raised $4m in funding.
The company intends to use the funds to develop and commercialize a new test for lung, breast, prostate and colorectal cancer.
Led by Bill Colston, co-founder and CEO, HealthTell is based on diagnostics technology developed at the ASU Biodesign Institute by Dr. Stephen A. Johnston and Dr. Neal Woodbury and licensed through Arizona Technology Enterprises (AzTE), the technology transfer arm of ASU.
The company measures the body’s immunosignature to a given disease or disease state to provide a broad menu of accurate tests that are capable of detecting it earlier and less invasively than today.
HealthTell is also supplying chips for two ASU projects funded by the U.S. Department of Defense and its Defense Threat Reduction Agency (DTRA).
The company employs more than 20 people at the Innovations Incubator in Chandler.